Prostate Cancer
Dynamic phase separation of the androgen receptor and its coactivators key to regulate gene expression.
December 22, 2022
Ambient exposures to selected volatile organic compounds and the risk of prostate cancer in Montreal.
December 22, 2022
Clinical Validation of Artificial Intelligence-Augmented Pathology Diagnosis Demonstrates Significant Gains in Diagnostic Accuracy in Prostate Cancer Detection.
December 22, 2022
Ipsilateral hemigland prostate biopsy may underestimate cancer burden in patients with unilateral mpMRI-visible lesions.
December 21, 2022
Optimal assessment of quality of life for patients with prostate cancer.
December 21, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.
December 21, 2022
Lantheus Announces Closing of Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 with POINT Biopharma
December 20, 2022
Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent Outcome.
December 20, 2022
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy.
December 20, 2022
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance.
December 20, 2022
Undergoing radical treatment for prostate cancer and its impact on wellbeing: A qualitative study exploring men's experiences.
December 20, 2022